Clinical Pharmacy

CP-067

USE OF VALIDATED CARE QUALITY INDICATORS TO IDENTIFY MPROVEMENTS IN HIV PHARMACEUTICAL CARE

CP-066

PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS: A CASE REPORT

CP-065

SWITCHING ANTIRETROVIRAL THERAPY: REASONS AND ASSOCIATED COSTS IN A COHORT OF HIV-INFECTED PATIENTS

CP-064

ANALYSIS OF ORAL IMMUNOSUPPRESSANT USE IN OFF-LABEL INDICATIONS IN A HOSPITAL PHARMACY SERVICE

CP-063

PHARMACY ASSISTANCE FOR FRAIL PATIENTS WITH NASOGASTRIC TUBE

CP-062

COST IMPACT OF BELIMUMAB IN A HOSPITAL SETTING

CP-060

COMPARISON OF ETHNIC CHRISTIAN AND MUSLIM POPULATIONS ON ANTIRETROVIRAL TREATMENT

CP-058

PHARMACEUTICAL CARE SYSTEM FOR CHRONIC PAEDIATRIC PATIENTS

CP-057

DOSAGE ADJUSTMENT OF EPOETIN ß AND DARBEPOETIN a IN CHRONIC KIDNEY DISEASE

CP-055

PHARMACY INTERVENTIONS IN VENOUS THROMBOEMBOLISM PROPHYLAXIS IN MEDICAL PATIENTS

CP-054

OFF-LABEL USE OF EMTRICITABINE / RILPIVIRINE / TENOFOVIR

CP-053

IDENTIFICATION OF A NATIONAL PORTFOLIO OF UNLICENSED PHARMACEUTICAL PREPARATIONS IN DENMARK

CP-051

EVALUATION OF ELECTRONIC DRUG INTERACTION CHECKER DATABASES - RHEUMATOID ARTHRITIS PATIENTS CASE STUDY

CP-050

POSACONAZOLE AND INVASIVE FUNGAL INFECTION

CP-049

CLINICAL RELEVANCE OF RECONCILIATION ERRORS AT ADMISSION FROM EMERGENCY DEPARTMENT AVOIDED BY THE CLINICAL PHARMACIST

Pages